Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU

Journal of Controlled Release

Volumn 42, Issue 1, 1996, Pages 83-92

  Dang, Wenbin ^a   Daviau, Todd ^a   Ying, Peter ^a   Zhao, Yong ^a   Nowotnik, David ^a   Clow, Charles S ^a   Tyler, Betty ^b   Brem, Henry ^b  

^a GUILFORD PHARMACEUTICALS INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biodegradable polymer; Brain tumor; GLIADEL; Molecular weight effect; Polyanhydride

Indexed keywords

CARMUSTINE; POLYANHYDRIDE; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; DRUG RELEASE; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030272598     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01371-5     Document Type: Article

References (32)

1. [1] C.T. Laurencin, T. Gerhart, P. Witschger, R. Satcher, A. Domb, A.E. Rosenberg, P. Hanff, L. Edsberg, W. Hayes and R. Langer, Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J. Orthopaed. Res. 11 (1993) 256-262.
2. [2] M. Howard, A. Gross, M. Grady, R. Langer, E. Mathiowitz, R. Winn and M. Mayberg, Intracerebral drug delivery in rats with lesion-induced memory deficits. J. Neurosurg. 71 (1989) 105-112.
3. [3] M. Yang, R. Tamargo and H. Brem, Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. Cancer Res. 49 (1989) 5103-5107.
4. [4] H. Brem, M. Mahaley, N. Vick, K. Black, S. Schold, P. Burger, A. Friedman, I. Ciric, T. Eller, J. Cozzens and J. Kenealy, Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg. 74 (1991) 441-446.
5. [5] M. Chasin, G. Hollenbeck, H. Brem, S. Grossman, M. Colvin and R. Langer, Interstitial drug therapy for brain tumors: a case study. Drug Dev. Ind. Pharm. 16 (1990) 2579-2594.
6. [6] S.A. Grossman, C.S. Reinhard, H. Brem, R. Brundrette, M. Chasin, R. Tamargo and O.M. Colvin, The intracerebral delivery of BCNU with surgically implanted bioerodible polymers: a quantitative autoradiographic study. Proc. Am. Soc. Clin. Oncol. 7 (1988) 84.
7. [7] R.J. Tamargo, J.S. Myseros, J.I. Epstein, M.B. Yang, M. Chasin and H. Brem, Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res. 53 (1993) 329-333.
8. [8] K. Judy, A. Olivi, K. Buahin, A. Domb, J. Epstein, O. Colvin and H. Brem, Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J. Neurosurg. 82 (1995) 481-486.
9. [9] K. Walter, M. Cahan, A. Gur, B. Tyler, J. Hilton, O. Colvin, P. Burger, A. Domb and H. Brem, Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res. 54 (1994) 2207-2212.
10. [10] K.G. Buahin, K.D. Judy, C. Hartke, A. Domb, M. Maniar, O.M. Colvin and H. Brem, Controlled release of 4-hydroperoxy-cyclophosphamide from the fatty acid dimersebacic acid copolymer. Polym. Adv. Technol. 3 (1992) 311-316.
11. [11] J.D. Weingart, E.P. Sipos and H. Brem, The role of minocycline in the treatment of intracranial 9L glioma. J. Neurosurg. 82 (1995) 635-640.
12. [12] H. Brem, S. Piantadosi, P. Burger, M. Walker, R. Selker, N. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz and S. Schold, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345 (1995) 1008-1012.
13. [13] S. Valtonen, G. Unsgaard, L. Kivipelto, O. Heiskanen and T. Kuurne. Placebo-controlled trial of GLIADEL placement at the time of first surgery for malignant glioma. in Eleventh International Conference on Brain Tumor Research and Therapy 1995, Napa, California.
14. [14] E. Mathiowitz, J. Jacob, K. Pekarek and D. Chickering III. Morphological characterization of bioerodible polymers. 3. Characterization of the erosion and intact zones in polyanhydrides using scanning electron microscopy. Macromolecules 26 (1993) 6766-6765.
15. [15] A. D'Emanuele, J. Hill, J. Tamada, A. Domb and R. Langer, Molecular weight changes in polymer erosion. Pharm. Res. 9 (1992) 1279-1283.
16. [16] E. Mathiowitz and R. Langer, Polyanhydride microspheres as drug carriers. I. Hot-melt microencapsulation. J. Control. Release 5 (1987) 13-22.
17. [17] E. Mathiowitz, W.M. Saltzman, A. Domb, P. Dor and R. Langer, Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal. J. Appl. Polym. Sci. 35 (1988) 755-774.
18. [18] M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber and R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10 (1993) 945-953.
19. [19] L.M. Sanders, J.S. Kent, G.I. McRae. B.H. Vickery, T.R. Tice and D.H. Lewis, Controlled release of a Iuteinizing hormone-releasing hormone analogue from poly(d,l-lactideco-glycolide) microspheres. J. Pharm. Sci. 73 (1984) 1294-1297.
20. [20] L.M. Sanders, B.A. Kell, G.I. McRae and G.W. Whitehead, Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implant: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75 (1986) 356-360.
21. [21] M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber and R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10 (1993) 945-953.
22. [22] F. Hutchinson and B. Furr, Biodegradable polymer systems for the sustained release of polypeptides. J. Control. Release 13 (1990) 279-294.
23. [23] T.G. Park, Degradation of poly(D,L-lactic acid) microspheres: effect of molecular weight. J. Control. Release 30 (1994) 161-173.
24. [24] F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides. J. Control. Release 13 (1990) 279-294.
25. [25] D. Bodmer, T. Kissel and E. Traechslin, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Control. Release 21 (1992) 129-138.
26. [26] A. Domb, S. Amselem, J. Shah and M. Maniar, Polyanhydrides: synthesis and characterization. Adv. Polym. Sci. 107 (1993) 94-141.
27. [27] E. Mathiowitz, C. Amalo, P. Dor and R. Langer, Polyanhydride microspheres. 3. Morphology and characterization of systems made by solvent removal. Polymer 31 (1990) 547-555.
28. [28] J. Tamada and R. Langer. Review: the development of polyanhydrides for drug delivery applications. J. Biomater. Sci. 3 (1992) 315-353.
29. [29] E. Mathiowitz, E. Ron, G. Mathiowitz, C. Amato and R. Langer, Morphological characterization of bioerodible polymers. I. Crystallinity of polyanhydride copolymers. Macromolecules 23 (1990) 3212-3218.
30. [30] H.T. Wang, H. Palmer, R.J. Linhardt, D.R. Flanagan and E. Schmitt, Degradation of poly(ester) microspheres. Biomaterials 11 (1990) 679-685.
31. [31] S.J. Holland, A.M. Jolly, M. Yasin and B.J. Tighe, Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: hydrolytic degradation studies. Biomaterials 8 (1987) 289-295.
32. [32] W. Dang, T. Daviau and H. Brem, Morphological characterization of polyanhydride biodegradable implant Gliadel: in vitro and in vivo erosion using scanning electron microscopy, Pharm. Res. 13 (1996) 683-691.